![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 23, 2015 4:53:12 PM
These are 3 separate pipeline developments. Furthermore, keep in mind that C. Ichim's contract gave her 18 months to acquire all her incentive shares and she signed a contract that gave her bonus shares for establishment of 3 INDs and 3 contracts for clinical trials as I recall. Those bonus shares expire June 2016. So, in their minds, there was a real possibility of having 3 pipeline products in clinical trials by June 2016.
Also need be mentioned is Harry Lander and his role(s), along with the scientific advisory board members and all of their connections and specializations. The company is only getting better; and there is now adequate DD for all to take notice of. Great post!
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM